153.00
-0.40
(-0.26%)
At close: January 10 at 4:59:44 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 5 | 5 |
Avg. Estimate | 0 | 0 | 4.02 | 5.48 |
Low Estimate | 0 | 0 | 3.83 | 5.15 |
High Estimate | 0 | 0 | 4.37 | 5.71 |
Year Ago EPS | 0.7 | 1.1 | 2.2 | 4.02 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 5 | 5 |
Avg. Estimate | -- | -- | 5.56B | 6.19B |
Low Estimate | -- | -- | 5.54B | 6.12B |
High Estimate | -- | -- | 5.58B | 6.26B |
Year Ago Sales | -- | -- | 4.82B | 5.56B |
Sales Growth (year/est) | -- | -- | 15.28% | 11.37% |
Earnings History
Currency in DKK | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | 0.77 | 0.96 | 0.75 | 0.79 |
EPS Actual | 0.7 | 1.1 | 0.9 | 1 |
Difference | -0.07 | 0.14 | 0.15 | 0.21 |
Surprise % | -9.09% | 13.99% | 20.00% | 26.58% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 4.02 | 5.48 |
7 Days Ago | 0 | 0 | 3.91 | 5.41 |
30 Days Ago | 0 | 0 | 3.91 | 5.41 |
60 Days Ago | 0 | 0 | 3.89 | 5.43 |
90 Days Ago | 0 | 0 | 3.89 | 5.43 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | 1 | 1 |
Up Last 30 Days | -- | -- | -- | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | -- | 4 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ALK-B.CO | -- | -- | 82.84% | 36.23% |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
GMAB.CO Genmab A/S
1,607.50
+0.09%
ZEAL.CO Zealand Pharma A/S
735.00
+0.07%
BAVA.CO Bavarian Nordic A/S
201.60
-0.84%
GUBRA.CO Gubra A/S
666.00
-1.48%
FLUO.ST FluoGuide A/S
46.70
-2.91%
SANION.ST Saniona AB (publ)
6.80
-3.00%
PILA.ST Pila Pharma AB (publ)
4.5700
-2.97%
BIOSGN.ST Biosergen AB
0.5400
-4.26%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
23.00
-2.54%
HNSA.ST Hansa Biopharma AB (publ)
34.78
-0.69%